• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Seventh Sense Biosystems Inc.

Seventh Sense Biosystems wins FDA nod for blood collection device

February 23, 2017 By Sarah Faulkner

Seventh Sense Biosystems said today its Tap blood collection device won FDA 510(k) clearance. The company’s push-botton device collects capillary blood for hemoglobin A1C testing without the use of large needles. The Tap device is designed to be placed on the upper arm and blood collection, which takes 2 to 3 minutes, begins with a […]

Filed Under: 510(k), Blood Management, Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: Seventh Sense Biosystems Inc.

Seventh Sense raises $10m in Series C

November 18, 2016 By Fink Densford

Seventh Sense Biosystems said  today it raised $10 million in a Series C funding round to support its Tap push-button blood collection device, as well as new product development and increasing production capacity. Joining the round are existing investors Novartis, Laboratory Corp of America Holdings, Polaris Partners and Flagship Ventures. “We’re bolstered by the confidence our […]

Filed Under: Blood Management, Business/Financial News Tagged With: Seventh Sense Biosystems Inc.

Seventh Sense launches pivotal trial for Tap100 blood draw device

April 13, 2016 By Fink Densford

Seventh Sense Biosystems said today it launched a pivotal trial for its Tap100 touch activated blood collection device. Medford, Mass.-based Seventh Sense said it expects to file for marketing authorization in the U.S. and European Union in the 2nd quarter of 2016, with a hopeful date for CE Mark approval in the European Union and […]

Filed Under: Blood Management, Clinical Trials Tagged With: Seventh Sense Biosystems Inc.

HealthQuest Capital looks to investments with its new $110M funding round | Medtech funding for the week of August 18, 2014

August 22, 2014 By MassDevice Leave a Comment

HealthQuest Capital raises $110M for healthcare investments

August 19, 2014 by Arezu Sarvestani

HealthQuest Capital raises $110M for healthcare investments

Filed Under: Funding Roundup, News Well Tagged With: electroCore, HealthQuest Capital, Patient-Centered Outcomes Research Institute (PCORI), Piper Jaffray, Seventh Sense Biosystems Inc., Sofinnova Partners

Seventh Sense lands $16M for non-invasive blood collection

August 13, 2014 By Arezu Sarvestani Leave a Comment

Seventh Sense lands $16M for blood collection tech

Massachusetts-based Seventh Sense Biosystems added 3 new investors this month with the closing of its Series B financing round, which brought in $16 million for the the company’s blood sampling devices.

Filed Under: Blood Management, Funding Roundup, News Well Tagged With: Seventh Sense Biosystems Inc.

Seventh Sense names Howard Weisman president, CEO, board member | Personnel Moves

June 13, 2012 By MassDevice staff Leave a Comment

fired/hired

 Seventh Sense Biosystems names Howard Weisman president & CEO

Filed Under: News Well Tagged With: BioDrain Medical Inc., EarlySense, Personnel Moves, Seventh Sense Biosystems Inc.

Lost lawsuit pushes HemCon Medical into bankruptcy | Wall Street Beat

April 11, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

HemCon Medical Technologies said it’s filing for Chapter 11 bankruptcy protection for its U.S. operation after losing a $34.2 million court decision last month, saying it plans to appeal the ruling.

In March a sharply split U.S. Court of Appeals for the Federal Circuit reversed course and reinstated a win for Marine Polymer Technologies in its wound dressing patent spat with HemCon.

Filed Under: Legal News, News Well, Wall Street Beat Tagged With: Aleva Neurotherapeutics, Bankruptcy, becton dickinson, Corning Inc., Danaher Corp., H.I.G. Bioventures, HemCon Medical Technologies Inc., Intuitive Surgical, Laser Engineering Inc., Lumenis Ltd., Marine Polymer Technologies Inc., MaxiFlex, Olympus, Orgenesis, PositiveID Corp., Premier Inc., Pyng Medical, Seventh Sense Biosystems Inc.

Mela Sciences announces $15M public offering | Funding Roundup

December 16, 2011 By MassDevice staff Leave a Comment

Mela Sciences (NSDQ:MELA) priced a public offering of 5 million shares of common stock at $3.25 per share, hoping to raise up to $14.9 million.

President & CEO Joseph Gulfo and director Robert Coradini agreed to purchase 43,000 shares at the Dec. 15 closing price of $3.97 per share.

Filed Under: Funding Roundup, News Well, Oncology Tagged With: Apax Partners, Bill & Melinda Gates Foundation, Kinetic Concepts Inc., LifeServe Innovations LLC, MELA Sciences Inc., Radius Health, Seventh Sense Biosystems Inc., titanmedical

Quintiles aims to restructure debt with $2 billion in credit | Funding roundup

May 13, 2011 By MedCity News

Funding

Quintiles is resuming its plans to raise more than $2 billion in bank financing.

The Durham, N.C.-based, contract research organization is planning to enter into a new $2.2 billion credit facility, with proceeds from the borrowed funding being used to refinance $1.7 billion in existing debt, including an offer to buy $525 million of 9.5 percent outstanding senior notes that are due in 2014.

Filed Under: News Well Tagged With: Advanced BioHealing Inc., Angiotech, Avedro Inc., CardioDx Inc., Cardiva Medical Inc., DaVita Inc., Lantheus Medical Imaging, Life Technologies Corp., MindChild Medical Inc., MoMelan Technologies, Quintiles, Seventh Sense Biosystems Inc., Sorin Group, Varian Medical Systems, Venture Capital/Private Equity, WaveMark Inc., WaveTec Vision

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS